Why I Joined S4PM – Christine Bienvenu – Switzerland
Christine Bienvenu I started becoming an ePatient in 2008 when we were looking for a diagnosis for my eldest son (Aspergers Syndrome) and when I was diagnosed with breast cancer at age 35 in 2010. I naturally empowered myself to better understand and deal my new health reality. Researching my illness online I realised that French-speaking Switzerland had no breast cancer community and so through Facebook and Twitter I created Seinplement Romand(e)s, the breast cancer community I would have liked to find when I was diagnosed. Becoming an ePatient and then spreading awareness about it was not and is not an easy feat in paternalistic conservative Switzerland. Through Twitter then Facebook I was able to meet ePatient Dave after reading his book Let Patients Help! which was a revelation to me because I could finally put words on the experiences I was living. I felt the French community needed to have access to Dave’s message of empowerment and patient-healthcare professional collaboration, so that patients here could start taking back their rightful place in the medical partnership. Today, my empowerment and patient community experience and knowledge has given me the authority to become a professional ePatient at the Lausanne and Geneva University Hospitals and to give classes and training to healthcare professionals throughout French-speaking Switzerland. Although things have moved forward in the years since I’ve started my ePatient journey, we are still very few pat...
Conclusions: CIN2 progression is uncommon in this population, regardless of CIN2 treatment. Additional studies are needed to identify factors to differentiate women at highest risk of CIN2 progression.
Conclusion: The assessment of demarcation of EGC using M-NBI was excellent in well-differentiated (WD) adenocarcinoma and lesions below 20 mm in size. However, histopathological confirmation is needed to assess the demarcation of non-WD adenocarcinomas and EGC over 20 mm in size.Digestion
PANCREATIC cancer is the deadliest common cancer in the UK. In order to catch the disease early and make treatment easier, it ’s imperative to know what symptoms to look out for.
Caiyun Li, Hongyan Liu, Yunqing Yang, Xixi Xu, Tongtong Lv, Huidan Zhang, Kehang Liu, Shuangquan Zhang, Yuqing Chen
Luca Falzone, Salvatore Salomone, Massimo Libra
“I’m a medical student. Which specialty should I choose and what skills will a future doctor need?” “I’m in radiology. Looking at the recent advancements in medical technology, was it a wise choice or should I train myself in something different, too?” These are the questions I most frequently receive after my keynote speeches. While all should be aware of their own physical and intellectual capabilities, here are a few pieces of advice which skills to concentrate on based on the current and future trends in healthcare. The most significant trends in healthcare Artificial intelligence, w...
Latifa Jackson, Hasan Jackson, Mariam Mohammed, Nicholas Guthrie, Shihyun Kim, Rita Okolo, Fatimah Jackson
Sergio Gonz ález Rubio, Nuria Montero Pastor, Carolina García, Víctor G. Almendro-Vedia, Irene Ferrer, Paolo Natale, Luis Paz-Ares, M. Pilar Lillo, Iván López-Montero
Fanny Onodi, Chahrazed Maherzi-Mechalikh, Alice Mougel, Nadine Ben Hamouda, Charlotte Taboas, Fabien Gueugnon, Thi Tran, Herve Nozach, Elodie Marcon, Alain Gey, Magali Terme, Ahmed Bouzidi, Bernard Maillere, J érôme Kerzerho, Eric Tartour, Corinne Tanchot